Tanuku and Patalganga API sites win safety and employer awards
Patalganga (Maharashtra) API site won the National Safety Council's "Certificate of Excellence" for safety performance, for the third consecutive year.
By ScoutQuest · · 1 min read
- Safety Award - Patalganga
- National Safety Council's "Certificate of Excellence" for safety performance
- Employer Award - Tanuku
- "Best Employer" by the State Government for employee practices and workplace culture
- Award Frequency
- for the third consecutive year
Two of Wanbury's API manufacturing sites have received outside recognition, one for safety performance and one for employer practices.
What was announced
- Patalganga, Maharashtra (API manufacturing): received the "Certificate of Excellence" from the National Safety Council for safety performance, for the third consecutive year.
- Tanuku, Andhra Pradesh (API manufacturing): received the "Best Employer Award" from the State Government, recognising its employee practices and workplace culture.
How to read it
These are non-financial recognitions from a safety body and a State Government. On their own they do not change revenue, costs, capacity or output; they reflect how the plants are run in terms of safety and people practices.
Management comment
"Our people and their safety are at the heart of everything we do," said Mr. Mohan Rayana, Director of Wanbury Limited. He said the awards recognise the teams' dedication to a safe, compliant and rewarding workplace, and that the company will keep raising the bar on employee welfare and safety across all its sites.
Company context
- Established in 1988 and listed on the NSE (code WANBURY) and BSE (code 524212).
- The company says its APIs are exported to over 50 countries and that it has a Pan-India formulation presence.
- It describes USFDA and EUGMP approved facilities at Tanuku (Andhra Pradesh) and Patalganga (Maharashtra). The API portfolio spans antidiabetic, antidepressant, pain management, antihistamine and anti-inflammatory products, among others.
Also from Wanbury
Wanbury gets 9 USFDA 'No DMF Deficiency' letters for Metformin HCl; new business in Saudi Arabia and Mexico
16 Oct 2026
Subsidiary launches berrysoft™ baby product range across multiple states, marks entry into paediatric dermatology
12 Oct 2026
Subsidiary launches berrysoft baby product range across multiple states, enters paediatric dermatology
12 Oct 2026
More numbers
- Consecutive years for National Safety Council Certificate of Excellencethird consecutive year
- Countries to which APIs are exportedover 50 countries
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.